Challenges in the diagnosis of Parkinson's disease
Parkinson's disease is the second most common neurodegenerative disease and its
prevalence has been projected to double over the next 30 years. An accurate diagnosis of …
prevalence has been projected to double over the next 30 years. An accurate diagnosis of …
Clinical diagnostic criteria for dementia associated with Parkinson's disease
…, N Quinn, C Sampaio, E Tolosa… - … : official journal of the …, 2007 - Wiley Online Library
Dementia has been increasingly more recognized to be a common feature in patients with
Parkinson's disease (PD), especially in old age. Specific criteria for the clinical diagnosis of …
Parkinson's disease (PD), especially in old age. Specific criteria for the clinical diagnosis of …
Criteria for the diagnosis of corticobasal degeneration
…, SE Lee, BL Miller, SG Reich, DE Riley, E Tolosa… - Neurology, 2013 - AAN Enterprises
Current criteria for the clinical diagnosis of pathologically confirmed corticobasal
degeneration (CBD) no longer reflect the expanding understanding of this disease and its …
degeneration (CBD) no longer reflect the expanding understanding of this disease and its …
The O nset of N onmotor S ymptoms in P arkinson's disease (T he ONSET PD S tudy)
…, M Salamero, W Poewe, E Tolosa - Movement …, 2015 - Wiley Online Library
Nonmotor symptoms (NMS) in Parkinson's disease (PD) can precede onset of motor symptoms.
Relationship between premotor symptoms onset and motor features is limited. Our aim is …
Relationship between premotor symptoms onset and motor features is limited. Our aim is …
LRRK2 in Parkinson disease: challenges of clinical trials
One of the most common monogenic forms of Parkinson disease (PD) is caused by mutations
in the LRRK2 gene that encodes leucine-rich repeat kinase 2 (LRRK2). LRRK2 mutations, …
in the LRRK2 gene that encodes leucine-rich repeat kinase 2 (LRRK2). LRRK2 mutations, …
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
…, S Goldwurm, JJ Ferreira, E Tolosa… - The Lancet …, 2008 - thelancet.com
Background Mutations in LRRK2, the gene that encodes leucine-rich repeat kinase 2, are a
cause of Parkinson's disease (PD). The International LRRK2 Consortium was established to …
cause of Parkinson's disease (PD). The International LRRK2 Consortium was established to …
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force
…, W Poewe, C Sampaio, E Tolosa… - Movement …, 2007 - Wiley Online Library
A preceding article described the clinical features of Parkinson's disease dementia (PD‐D)
and proposed clinical diagnostic criteria for “probable” and “possible” PD‐D. The main focus …
and proposed clinical diagnostic criteria for “probable” and “possible” PD‐D. The main focus …
[PDF][PDF] Clinical rating scale for tremor
S Fahn, E Tolosa, C Marín - Parkinson's disease and movement …, 1993 - researchgate.net
The word tremor is derived from the Latin tremere, meaning “to tremble.” Tremor can be
defined as involuntary oscillations of any part of the body around any plane, such oscillations …
defined as involuntary oscillations of any part of the body around any plane, such oscillations …
The diagnosis of Parkinson's disease
The correct diagnosis of Parkinson's disease is important for prognostic and therapeutic
reasons and is essential for clinical research. Investigations of the diagnostic accuracy for the …
reasons and is essential for clinical research. Investigations of the diagnostic accuracy for the …
[HTML][HTML] A double-blind, delayed-start trial of rasagiline in Parkinson's disease
…, W Poewe, F Stocchi, E Tolosa - … England Journal of …, 2009 - Mass Medical Soc
Background A therapy that slows disease progression is the major unmet need in Parkinson's
disease. Methods In this double-blind trial, we examined the possibility that rasagiline has …
disease. Methods In this double-blind trial, we examined the possibility that rasagiline has …